# Graft-versus-Host Diseases: Developing Drugs, Biological Products, and Certain Devices for Prevention or Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/graft-versus-host-diseases-developing-drugs-biological-products-and-certain-devices-for-prevention-or-treatment/30eba576-b6ea-4536-918e-e634aefadcc4

> FDA guidance document: Graft-versus-Host Diseases: Developing Drugs, Biological Products, and Certain Devices for Prevention or Treatment. Issue date: September 28, 2023. Get complete insights and analysis.

---

## Details

- Title: Graft-versus-Host Diseases: Developing Drugs, Biological Products, and Certain Devices for Prevention or Treatment
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2023-09-28
- Comment Close Date: 2023-11-28
- Last Changed: 2023-09-28
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2023-D-3900">FDA-2023-D-3900</a>

## Related Documents

- [Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Developing Drug and Biological Products in Oncology](https://www.globalkeysolutions.net/guidances/guidance-document/prevention-and-treatment-of-chemotherapy-induced-peripheral-neuropathy-developing-drug-and-biological-products-in-oncology/21c15304-ad79-4fb0-8609-1712f3c9952b)
- [Purpose and Content of Use-Related Risk Analyses for Drugs, Biological Products, and Combination Products](https://www.globalkeysolutions.net/guidances/guidance-document/purpose-and-content-of-use-related-risk-analyses-for-drugs-biological-products-and-combination-products/53619b8d-27a9-4506-b006-144d1a9be3d4)
- [Osteoarthritis: Structural Endpoints for the Development of Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/osteoarthritis-structural-endpoints-for-the-development-of-drugs/8fba9dbf-fb3b-42a9-8837-a2ce4870eba1)